Old Web
English
Sign In
Acemap
>
authorDetail
>
Maki Nishiya
Maki Nishiya
Iwate Medical University
Internal medicine
Medicine
Meropenem
Randomized controlled trial
Immunology
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
[Treatment of secondary engraftment failure with granulocyte colony-stimulating factor and eltrombopag after allogeneic peripheral blood stem cell transplantation in adult T-cell leukemia/lymphoma].
2021
The Japanese journal of clinical hematology
Kazuki Kiyohara
Norifumi Sugawara
Takahiro Maeta
Shinri Miyajima
Motoki Takano
Masao Nishiya
Maki Nishiya
Ryousei Sasaki
Yoshiaki Okano
Satsuki Kamihara
Shugo Kowata
Tatsuo Oyake
Shigeki Ito
Show All
Source
Cite
Save
Citations (0)
Case of secondary MDS/MLD in Ph positive CML treated by dasatinib
2019
Maki Nishiya
Show All
Source
Cite
Save
Citations (0)
Doripenem Versus Meropenem As the First-Line Mono-Therapy in High-Risk Febrile Neutropenic Patients with Acute Leukemia: A Randomized, Controlled Trial
2019
Blood
Tatsuo Oyake
Norifumi Sugawara
Shinri Miyajima
Kazuki Kiyohara
Maki Nishiya
Tadashi Shimoyama
Yuka Takemasa-Fujisawa
Ryosei Sasaki
Wataru Izumita
Yasuhiko Tsukushi
Akihiro Otsu
Takahiro Mine
Takeshi Sugawara
Yuzo Suzuki
Yoshiaki Okano
Ichiro Hanamura
Shugo Kowata
Shigeki Ito
Show All
Source
Cite
Save
Citations (0)
1